Clinical Trial Update: MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing [NA]

View source ↗

Summary

Clinical trial update from the Medical College of Wisconsin describes a study using targeted antithymocyte globulin dosing to deplete alpha/beta T cells and B c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia in Remission
• Acute Myeloid Leukemia in Remission
• Biphenotypic Acute Leukemia
• Chronic Myeloid Leukemia Accelerated Phase
• Chronic Myeloid Leukemia Chronic Phase
• Chronic Myeloid Leukemia in Blast Crisis
• Lymphoblastic Lymphoma
• Myelodysplastic Syndromes

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Leukemia, Acute Myeloid Leukemia in Remission | NA | Status: RECRUITING